Henry Horhey

Doctor of Osteopathic Medicine,  Toronto General - University Health Network 

Location: Germany

Consulting Services

Data Science-Bioinformatics IT-Web-Mobile Technology Legal Support Career Advice and Mentoring Sales and Marketing

Areas Of Interest

Tube, Uterine Waldenstrom Hyperglobulinemic Purpura Familial Tremors Rete Testis Operations, Arterial Switch Eosinophilic Pneumonia, Tropical Preneoplastic Condition Mitragyna speciosas Invasive Candidiases Proteinases, Serine Initiation, Protein Translation Thrombocytes Mice, Lurcher Diversity, Antibody Acid Hydroxylase, Lauric Diacylglycerols Hermit Crabs PACAP Type III Receptor Health Services, Suburban Inducible T Cell Co Stimulator Ligand Cyclopentanes AmantaSulfateAZU Bang Disease Disorder, Complex Partial Seizures Job Applications Triprolidine Monohydrochloride, Monohydrate Complement 3 Proactivator Golgi Cells, Cerebellar Mixed Gonadal Dysgenesis Forcep, Obstetric Reticulosis, Familial Hemophagocytic Cells, HCT 116 Polyarteritis, Essential MMP12 Metalloproteinase Genes, THRB Hereditary Ventricular Hypertrophy CT, Spiral Cone-Beam Halospor

Professional Narrative

Dr. Henry Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Mayo Clinic 2009
Medical Writer, Amgen 2000

Education

Director Medicine, Perelman School of Medicine 2011
Doctor of osteopathic medicine, Yale School of Medicine 2003

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :